Dergiler / Clinical and Experimental Health Sciences / 2021 / Cilt: 11 - Sayı: 2

The Effect of Probiotic and Omega-3 Supplements on Total Oxidant and Total Antioxidant Levels in Experimental Colitis

Sayfa
362–366
Yayın Tarihi
2021-06-30
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The aim of the study is to evaluate the effects of probiotics and omega-3 fatty acids on total oxidant and total antioxidant levels in an experimental colitis model.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Treatment of inflammatory bowel disease (IBD) usually involves medical therapy.
📊
Temel Bulgular & Veri:For this reason, it is recommended to seek alternative treatment methods such as nutritional therapy.
💡
Sonuç & Katkı:The aim of the study is to evaluate the effects of probiotics and omega-3 fatty acids on total oxidant and total antioxidant levels in an experimental colitis model.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:probiotics · omega-3 fatty acids · total antioxidant level

Abstract

Objective: Treatment of inflammatory bowel disease (IBD) usually involves medical therapy. For this reason, it is recommended to seek alternative treatment methods such as nutritional therapy. The aim of the study is to evaluate the effects of probiotics and omega-3 fatty acids on total oxidant and total antioxidant levels in an experimental colitis model.

🔖

Bu Makaleye Atıf Yap

İLKTAÇ, H. Y., KIZILTAN, G., OZANSOY, M., KILIÇ, Ü., TOĞAY, S. Ö., KESKİN, İ., ÖZDEMİR, E. M., GÜNAL, M. Y. (2021). The Effect of Probiotic and Omega-3 Supplements on Total Oxidant and Total Antioxidant Levels in Experimental Colitis. Clinical and Experimental Health Sciences, Cilt: 11 - Sayı: 2, 362–366. https://ajindex.com/articles/481328

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007 May;369(9573):1627–40
  2. Sands BE. From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation. Gastroenterology. 2004 May;126(6):1518–32
  3. Sarma A, Rahaman Mallick A, Ghosh A. Free Radicals and Their Role in Different Clinical Conditions: An Overview. Int J Pharma Sci Res. 2010 Apr 1;1
  4. Satsangi J, Silverberg M, Vermeire S, Colombel J-F. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55: 749-753. Gut. 2006 Jul 1;55:749–53
  5. Buyukuslu N, Yigitbasi T. Reactive Oxygen Species and Oxidative Stress in Obesity. J Marmara Univ Inst Heal Sci. 2015;5(3):1
  6. Aghdassi E, Wendland BE, Steinhart AH, Wolman SL, Jeejeebhoy K, Allard JP. Antioxidant vitamin supplementation in Crohn’s disease decreases oxidative stress. a randomized controlled trial. Am J Gastroenterol. 2003 Feb;98(2):348–53
  7. Catarzi S, Favilli F, Romagnoli C, Marcucci T, Picariello L, Tonelli F, et al. Oxidative state and IL-6 production in intestinal myofibroblasts of Crohn’s disease patients. Inflamm Bowel Dis. 2011 Aug;17(8):1674–84
  8. Keshavarzian A, Banan A, Farhadi A, Komanduri S, Mutlu E, Zhang Y, et al. Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease. Gut [Internet]. 2003 May;52(5):720–8. Available from:
  9. Krzystek-Korpacka M, Neubauer K, Berdowska I, Zielinski B, Paradowski L, Gamian A. Impaired erythrocyte antioxidant defense in active inflammatory bowel disease: impact of anemia and treatment. Inflamm Bowel Dis. 2010 Sep;16(9):1467–75
  10. Pinto MAS, Lopes MS-MS, Bastos STO, Reigada CLL, Dantas RF, Neto JCB, et al. Does active Crohn’s disease have decreased intestinal antioxidant capacity? J Crohns Colitis. 2013 Oct;7(9):e358-66
  11. Breganó JW, Dichi JB, Barbosa DS, El Kadri MZ, Matsuo T, Rodrigues MA, et al. Decreased total antioxidant capacity in plasma, but not tissue, in experimental colitis. Dig Dis Sci. 2009 Apr;54(4):751–7
  12. Kruidenier L, Kuiper I, Van Duijn W, Mieremet-Ooms MAC, van Hogezand RA, Lamers CBHW, et al. Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease. J Pathol. 2003 Sep;201(1):17–27
  13. Kruidenier L, Kuiper I, Lamers CBHW, Verspaget HW. Intestinal oxidative dam